Neumora Therapeutics, Inc. (NMRA)
1.39
-0.09
(-6.08%)
USD |
NASDAQ |
Aug 28, 16:00
1.38
-0.01
(-0.72%)
After-Hours: 20:00
Neumora Therapeutics Price to Book Value : 5.834 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 5.834 |
| August 27, 2026 | 6.212 |
| August 26, 2026 | 6.548 |
| August 25, 2026 | 6.296 |
| August 24, 2026 | 6.401 |
| August 21, 2026 | 6.841 |
| August 20, 2026 | 6.359 |
| August 19, 2026 | 6.883 |
| August 18, 2026 | 6.883 |
| August 17, 2026 | 6.380 |
| August 14, 2026 | 6.715 |
| August 13, 2026 | 7.261 |
| August 12, 2026 | 7.177 |
| August 11, 2026 | 7.135 |
| August 10, 2026 | 6.799 |
| August 07, 2026 | 6.841 |
| August 06, 2026 | 6.883 |
| August 05, 2026 | 6.757 |
| August 04, 2026 | 6.715 |
| August 03, 2026 | 6.883 |
| July 31, 2026 | 6.757 |
| July 30, 2026 | 6.925 |
| July 29, 2026 | 6.925 |
| July 28, 2026 | 7.051 |
| July 27, 2026 | 6.967 |
| Date | Value |
|---|---|
| July 24, 2026 | 6.254 |
| July 23, 2026 | 6.548 |
| July 22, 2026 | 6.464 |
| July 21, 2026 | 6.778 |
| July 20, 2026 | 6.841 |
| July 17, 2026 | 6.757 |
| July 16, 2026 | 6.715 |
| July 15, 2026 | 6.841 |
| July 14, 2026 | 6.631 |
| July 13, 2026 | 6.715 |
| July 10, 2026 | 7.051 |
| July 09, 2026 | 6.925 |
| July 08, 2026 | 6.673 |
| July 07, 2026 | 7.261 |
| July 06, 2026 | 7.093 |
| July 02, 2026 | 7.009 |
| July 01, 2026 | 6.799 |
| June 30, 2026 | 7.135 |
| June 29, 2026 | 4.433 |
| June 26, 2026 | 4.227 |
| June 25, 2026 | 3.892 |
| June 24, 2026 | 3.763 |
| June 23, 2026 | 4.149 |
| June 22, 2026 | 3.943 |
| June 18, 2026 | 3.892 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.597 |
| Indivior Pharmaceuticals, Inc. | -- |
| Liquidia Corp. | 30.91 |
| BioAge Labs, Inc. | 1.178 |
| LB Pharmaceuticals, Inc. | 4.119 |
Price to Book Value Related Metrics
| Price | 1.39 |
| Earnings Yield | -88.73% |
| Market Cap | 259.72M |